With 1 ETF traded in the U.S. markets, LifeSci Biotechnology Products Index ETF gathers total assets under management of $16.44M. The average expense ratio is 0.79%. LifeSci Biotechnology Products Index ETF can be found in the following asset class:
See the top-performing biotech ETFs and the potential benefits of investing.
New small/midcap fund will target stocks exhibiting steady dividend growth.
The segment is delivering some impressive gains after a bout of investor doubt.
New funds focus on environmental, social and governance standards for investing in emerging and developed markets.
The last quarter was a windfall for health care but are there other sectors you should consider?